What we do
About our project
The aim of the Dutch Covid & Trombosis Coalition (DCTC) consortium is to unravel the pathogenesis of immune-thrombosis in COVID-19 infection and optimize prevention and treatment strategies. The incidence of venous thromboembolic events (VTE) in COVID-19 patients is remarkably high, up to 48% on ICU despite thromboprophylaxis, suggesting a procoagulant state. Several underlying mechanisms have been suggested. To find the best possible treatment of COVID-19 patients we need to understand the pathogenesis and risk factors as well as the safety and efficacy of currently prescribed thromboprophylaxis and treatment.
Our team
Dr. M.J.H.A. Kruip, Department of Hematology is projectleader and secretary.
Prof. dr. E.C.M. van Gorp, Department of Viroscience, is co-projectleader,
Co-leaders in the Viroscience Department are dr. Barry Rockx and dr. Marco Goeijenbier.
